NCT00584064

Brief Summary

Emergency/compassionate use for the AMPLATZER PFO Occluder

Trial Health

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2007

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 2, 2008

Completed
Last Updated

April 11, 2019

Status Verified

April 1, 2019

First QC Date

December 20, 2007

Last Update Submit

April 9, 2019

Conditions

Keywords

patentforamenovalePFO

Interventions

Device closure with the AMPLATZER PFO Occluder

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Foramen Ovale, Patent

Condition Hierarchy (Ancestors)

Heart Septal Defects, AtrialHeart Septal DefectsHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
expanded access
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2007

First Posted

January 2, 2008

Last Updated

April 11, 2019

Record last verified: 2019-04